NNovo Nordisk Read More Novo Nordisk’s India Insulin Push and Aggressive Buyback Counterbalance a Pipeline Jolt2026-07-12 Novo Nordisk ended the week at €43.32, a 1.29% gain on Friday that masked a slightly negative weekly…